Menu
VJHemOnc Podcast
Podcast image
Myeloid Monthly: breaking news & updates from the classification advancement meeting
35 mins; April 02, 2026
How AI is transforming hematologic oncology
20 mins; March 27, 2026
MRD in ALL and AML: from prognostic marker to clinical endpoint
21 mins; March 20, 2026
Nursing in CAR-T & cellular therapy: updates and insights from the EBMT-EHA CAR T-cell Meeting 2026
17 mins; February 27, 2026
Recent BTK inhibitor trial updates across non-Hodgkin lymphoma subtypes
26 mins; February 20, 2026
ASH 2025 highlights in AL amyloidosis: risk stratification, bispecific antibodies, CAR-T, & MRD
28 mins; February 06, 2026
Top ASH 2025 updates in AML: redefining frontline therapy, menin inhibition, venetoclax-based triplets, & emerging immunotherapies
18 mins; January 30, 2026
Managing and preventing differentiation syndrome in APL
13 mins; January 22, 2026
Top ASH 2025 NHL updates: novel CAR T-cell therapies, fixed-duration strategies, evolving frontline approaches, & more
42 mins; January 16, 2026
Top updates in myeloma from ASH 2025: the RedirecTT-1 and MajesTEC-3 trials, dual-targeting CAR-T, trispecific antibodies, and more!
32 mins; January 09, 2026
Top CLL updates from ASH 2025: novel BTKi monotherapy and combination approaches, BTK degraders, & more
21 mins; December 18, 2025
Top updates in MDS from ASH 2025: key trial updates and debated topics
22 mins; December 12, 2025
Sickle cell disease management: navigating the transition from pediatric to adult care, managing VOCs, & more
18 mins; November 27, 2025
Accelerated- and blast-phase MPNs: diagnosis, management, and current challenges
18 mins; November 20, 2025
The value and utility of MRD in the management of adults with newly-diagnosed AML
16 mins; November 14, 2025
Updates from iwHRMM: targeted and immune-related therapies and mechanisms of resistance
24 mins; November 07, 2025
Advances in immunotherapy for NHL: updates from iwNHL 2025
34 mins; October 31, 2025
Reviewing recent guideline updates on the risk stratification and treatment of AML
28 mins; October 16, 2025
The management of CLL in resource-limited settings: guideline development and ongoing projects
19 mins; October 16, 2025
The multi-disciplinary team in CAR-T therapy: insights from a nurse, a neurologist, and a palliative care specialist
21 mins; September 29, 2025
Understanding financial and time toxicity in cancer care: advice for community oncologists
19 mins; September 19, 2025
Listener Q&A special: expert insights on CLL, myeloma, and lymphoma
29 mins; September 12, 2025
Novel strategies and advances in the management and classification of MDS: insights from iwMDS 2025
17 mins; September 04, 2025
Advances in Waldenström’s macroglobulinemia: significance of genetic alterations, current treatment strategies, & ongoing trials
15 mins; August 20, 2025
FLT3-ITD+ AML: recent trial updates, novel approaches, and MRD
18 mins; August 15, 2025
Extramedullary disease in multiple myeloma: biology, management strategies, & the RedirecTT-1 trial
16 mins; August 08, 2025
iwMPN 2025 highlights: novel approaches to the upfront management of myelofibrosis, cardiovascular health in MPNs, & more
23 mins; August 01, 2025
iwMPN 2025 highlights: novel approaches to the upfront management of myelofibrosis, cardiovascular health in MPNs, & more
23 mins; August 01, 2025
Managing CNS lymphoma: expert insights and updates from ICML 2025
23 mins; July 29, 2025
Managing CNS lymphoma: expert insights and updates from ICML 2025
23 mins; July 29, 2025
iwMDS wrap-up: translating research into practice to optimize patient care
23 mins; July 18, 2025
iwMDS wrap-up: translating research into practice to optimize patient care
23 mins; July 18, 2025
Targeting mutant CALR in MPNs with antibodies & cellular therapy: the potential for disease modification
20 mins; July 14, 2025
Targeting mutant CALR in MPNs with antibodies & cellular therapy: the potential for disease modification
20 mins; July 14, 2025
Treating elderly or unfit patients with AML: current approach and future directions
19 mins; July 04, 2025
Treating elderly or unfit patients with AML: current approach and future directions
19 mins; July 04, 2025
Key HemOnc updates from ASCO 2025: myeloma, lymphoma, MPNs, & more!
19 mins; June 30, 2025
Key HemOnc updates from ASCO 2025: myeloma, lymphoma, MPNs, & more!
19 mins; June 30, 2025
CHIP & CCUS: advances in understanding and should we treat these precursor conditions?
16 mins; June 20, 2025
CHIP & CCUS: advances in understanding and should we treat these precursor conditions?
16 mins; June 20, 2025
Diagnosing amyloidosis: identifying early signs, appropriate diagnostic tests, and challenges that remain
21 mins; June 14, 2025
Diagnosing amyloidosis: identifying early signs, appropriate diagnostic tests, and challenges that remain
21 mins; June 14, 2025
IPIG 2025 Highlights: challenging situations in PNH, updates from the COMMODORE trials, and more
20 mins; June 06, 2025
IPIG 2025 Highlights: challenging situations in PNH, updates from the COMMODORE trials, and more
20 mins; June 05, 2025
Recent advances in Hodgkin lymphoma treatment: novel regimens, ongoing trials & treating R/R disease
11 mins; May 30, 2025
Recent advances in Hodgkin lymphoma treatment: novel regimens, ongoing trials & treating R/R disease
11 mins; May 30, 2025
Gene therapy in sickle cell disease: patient selection, potential complications, & more
21 mins; May 23, 2025
Gene therapy in sickle cell disease: patient selection, potential complications, & more
21 mins; May 23, 2025
Highlights from iwCAR-T 2025: improving the efficacy and safety of CAR T-cells & access in the community
23 mins; May 19, 2025
Highlights from iwCAR-T 2025: improving the efficacy and safety of CAR T-cells & access in the community
23 mins; May 19, 2025
Updates to the ESMO CLL clinical practice guidelines and implications for relapsed therapy
19 mins; May 08, 2025
Updates to the ESMO CLL clinical practice guidelines and implications for relapsed therapy
19 mins; May 08, 2025
Highlights from iwMyeloma 2025: trial updates and practical considerations
35 mins; May 02, 2025
Highlights from iwMyeloma 2025: trial updates and practical considerations
35 mins; May 02, 2025
Updates to the ESMO CLL clinical practice guidelines: implications for frontline treatment
34 mins; April 25, 2025
Updates to the ESMO CLL clinical practice guidelines: implications for frontline treatment
34 mins; April 25, 2025
Highlights from EBMT 2025: preventing and managing GvHD, harnessing AI in transplant, & more
22 mins; April 17, 2025
Highlights from EBMT 2025: preventing and managing GvHD, harnessing AI in transplant, & more
22 mins; April 17, 2025
Sequencing therapies in R/R NHL: immunotherapy in DLBCL, BTKis in MCL, & more!
46 mins; April 14, 2025
Sequencing therapies in R/R NHL: immunotherapy in DLBCL, BTKis in MCL, & more!
46 mins; April 14, 2025
Novel CAR strategies being explored in lymphoma: allogeneic products, trispecific CARs & new manufacturing platforms
18 mins; March 31, 2025
Novel CAR strategies being explored in lymphoma: allogeneic products, trispecific CARs & new manufacturing platforms
18 mins; March 31, 2025
Approaches to optimizing induction therapy in AML: FLT3 inhibitors, menin inhibitors, CPX-351, & more!
23 mins; March 28, 2025
Approaches to optimizing induction therapy in AML: FLT3 inhibitors, menin inhibitors, CPX-351, & more!
23 mins; March 28, 2025
Treating R/R mantle cell lymphoma: the role of BTK inhibitors, combination approaches being explored & overcoming resistance
16 mins; March 24, 2025
Treating R/R mantle cell lymphoma: the role of BTK inhibitors, combination approaches being explored & overcoming resistance
16 mins; March 24, 2025
Addressing unmet needs in myeloma: early detection, frail/elderly patients, triple-class exposed disease, & more!
27 mins; March 14, 2025
Addressing unmet needs in myeloma: early detection, frail/elderly patients, triple-class exposed disease, & more!
27 mins; March 14, 2025
CAR T-cell therapy in ALL: trial updates, novel approaches, & real-world outcomes
18 mins; February 27, 2025
CAR T-cell therapy in ALL: trial updates, novel approaches, & real-world outcomes
18 mins; February 27, 2025
Post-ASH amyloidosis highlights: the ANDROMEDA trial, risk stratification, value of MRD, & more!
13 mins; February 21, 2025
Post-ASH amyloidosis highlights: the ANDROMEDA trial, risk stratification, value of MRD, & more!
13 mins; February 21, 2025
Post-ASH non-malignant highlights: updates in sickle cell disease, thalassemia, and hemophilia
18 mins; February 14, 2025
Post-ASH non-malignant highlights: updates in sickle cell disease, thalassemia, and hemophilia
18 mins; February 14, 2025
Post-ASH myeloma highlights: key takeaways for community physicians & trials to look out for in 2025
18 mins; February 06, 2025
Post-ASH myeloma highlights: key takeaways for community physicians & trials to look out for in 2025
18 mins; February 06, 2025
Post-ASH AML highlights: novel approaches to frontline therapy, advances with menin inhibitors, & managing FLT3-ITD+ AML
29 mins; January 31, 2025
Post-ASH AML highlights: novel approaches to frontline therapy, advances with menin inhibitors, & managing FLT3-ITD+ AML
28 mins; January 31, 2025
Post-ASH MPN highlights: key trial updates in MF, novel approaches being explored in R/R disease, & more!
22 mins; January 28, 2025
Post-ASH MPN highlights: key trial updates in MF, novel approaches being explored in R/R disease, & more!
22 mins; January 28, 2025
Post-ASH NHL highlights: novel combinations in the frontline setting and advancements with immunotherapy in the R/R setting
31 mins; January 24, 2025
Post-ASH NHL highlights: novel combinations in the frontline setting and advancements with immunotherapy in the R/R setting
31 mins; January 24, 2025
Post-ASH MDS highlights: managing anemia in LR-MDS and novel approaches to treating HR-MDS
19 mins; January 17, 2025
Post-ASH MDS highlights: managing anemia in LR-MDS and novel approaches to treating HR-MDS
19 mins; January 17, 2025
Post-ASH CLL highlights: BTK inhibitors & degraders, bispecific antibodies, & more!
16 mins; January 10, 2025
Post-ASH CLL highlights: BTK inhibitors & degraders, bispecific antibodies, & more!
16 mins; January 10, 2025
Advancing treatment for BPDCN: current therapies, a deep dive into tagraxofusp, & emerging novel agents
28 mins; December 18, 2024
Advancing treatment for BPDCN: current therapies, a deep dive into tagraxofusp, & emerging novel agents
28 mins; December 18, 2024
Improving care for patients with SCD: pain management, ongoing projects & unmet needs
16 mins; December 05, 2024
Improving care for patients with SCD: pain management, ongoing projects & unmet needs
16 mins; December 05, 2024
Understanding BPDCN: dermatology and hematology perspectives on presentation, diagnosis, treatment, & multidisciplinary care
34 mins; November 28, 2024
Understanding BPDCN: dermatology and hematology perspectives on presentation, diagnosis, treatment, & multidisciplinary care
34 mins; November 28, 2024
Managing complications associated with WM: Bing-Neel syndrome, acquired von Willebrand disease, & more!
21 mins; November 19, 2024
Managing complications associated with WM: Bing-Neel syndrome, acquired von Willebrand disease, & more!
21 mins; November 19, 2024
CAR-T therapies and bispecific antibodies in the treatment of high-risk multiple myeloma: updates from iwHRMM 2024
24 mins; November 12, 2024
CAR-T therapies and bispecific antibodies in the treatment of high-risk multiple myeloma: updates from iwHRMM 2024
24 mins; November 12, 2024
The treatment landscape and challenges in rare diseases: BPDCN, CMML, MPN-AP/BP, and VEXAS
22 mins; November 06, 2024
The treatment landscape and challenges in rare diseases: BPDCN, CMML, MPN-AP/BP, and VEXAS
22 mins; November 06, 2024
Exploring the role of BTK inhibitors in mantle cell lymphoma: sequencing & managing adverse events
9 mins; November 01, 2024
Exploring the role of BTK inhibitors in mantle cell lymphoma: sequencing & managing adverse events
9 mins; October 30, 2024
Click here to see more
Useful pages

Apply to teach

Reviews

Help & FAQs

Blog

Spanish Podcast

French Podcast

Italian Podcast

About Us

Contact Us

Terms & Privacy

Find a tutor

Arabic tutors

Chinese tutors

Dutch tutors

English tutors

French tutors

German tutors

Greek tutors

Italian tutors

Japanese tutors

Korean tutors

Portuguese tutors

Romanian tutors

Russian tutors

Spanish tutors

Swedish tutors

Thai tutors

More languages soon!

Languages

Learn Arabic

Learn Chinese

Learn Dutch

Learn English

Learn French

Learn German

Learn Greek

Learn Italian

Learn Japanese

Learn Korean

Learn Portuguese

Learn Romanian

Learn Russian

Learn Spanish

Learn Swedish

Learn Thai

© 2026 LanguaTalk, All Rights Reserved